Turn this list into an evaluation

Each entry is an FDA submission, not a distinct commercial offer. Inspect the exact record before comparing evidence, asking for a quote or planning an integration.

Prepare with a buyer guide:

Clinical guide links appear when this list contains a current reviewed example. They do not classify or endorse the other entries. All buyer guides · Compare exact records · Documented families

FDA-cleared K252421

JLK-NCCT

JLK, Inc.

Authorized purpose: Notification-only triage of adult non-contrast head CT for suspected intracranial hemorrhage and large-vessel occlusion, with parallel communication to trained clinicians during standard care.

Modality
CT/CTA
Anatomy
Brain and intracranial vessels: intracranial hemorrhage and LVO involving ICA, MCA-M1, and MCA-M2
Decision
2026-03-24
FDA-cleared K251983

Brainomix 360 Triage Stroke

Brainomix Limited

Authorized purpose: Triage and notification of suspected intracranial hemorrhage or anterior-circulation LVO on acute non-contrast head CT; not primary diagnosis.

Modality
CT/CTA
Anatomy
Brain/head, including intracranial ICA and M1 for LVO and intracranial hemorrhage findings
Decision
2025-08-26
FDA-cleared K251590

Methinks CTA Stroke

Methinks Software S.L.

Authorized purpose: Methinks CTA Stroke analyzes acute-setting brain CT angiography in adults over 21 with suspected stroke for suspected large-vessel occlusion in the terminal ICA, MCA-M1, or MCA-M2 and sends PACS and/or specialist notifications in parallel to standard care; previews are informational and not diagnostic.

Modality
CT/CTA
Anatomy
Brain
Decision
2025-08-20
FDA-cleared K251151

Rapid CTA 360

iSchemaView

Authorized purpose: Rapid CTA 360 analyzes adult head CTA DICOM images to flag suspected large- and medium-vessel occlusion in specified intracranial and vertebral segments and notify trained clinicians for workflow triage; notifications are informational and not diagnostic.

Modality
CT/CTA
Anatomy
Brain
Decision
2025-07-16
FDA-cleared K250685

Methinks NCCT Stroke

Methinks Software S.L.

Authorized purpose: Methinks NCCT Stroke analyzes adult non-contrast head CT to flag suspected intracranial hemorrhage and suspected large-vessel occlusion of the ICA, MCA-M1, or MCA-M2 for parallel workflow triage via PACS and/or notifications; previews are informational, not diagnostic, and a negative notification does not rule out LVO or replace CTA/standard care.

Modality
CT/CTA
Anatomy
Brain
Decision
2025-06-16
FDA-cleared K250831

Annalise Enterprise

Annalise-AI

Authorized purpose: Triage and prioritization of adult CXR and non-contrast brain CT studies for specified suspected findings, including pneumoperitoneum, pleural effusion, pneumothorax and tension pneumothorax on CXR, and acute extra-axial hemorrhage, subarachnoid hemorrhage, intra-axial hemorrhage, intraventricular hemorrhage, mass effect, obstructive hydrocephalus and vasogenic edema on brain CT.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Chest/Lung; Brain
Decision
2025-04-23
FDA-cleared K243611

JLK-SDH

JLK, Inc.

Authorized purpose: JLK-SDH analyzes non-contrast head CT for suspected hemispheric subdural hemorrhage and sends notification to a clinician for review in parallel to standard care; PACS/mobile previews may be compressed and are non-diagnostic, while full patient evaluation and uncompressed diagnostic viewing remain required.

Modality
CT/CTA
Anatomy
Head
Decision
2025-03-03
FDA-cleared K243294

Brainomix 360 e-ASPECTS

Brainomix Limited

Authorized purpose: Brainomix 360 e-ASPECTS registers adult non-contrast brain CT, segments ASPECTS regions, and provides an editable ASPECTS score with highlighted regions and voxel contribution views to assist trained clinicians evaluating suspected ischemic stroke within 24 hours of last known well.

Modality
CT/CTA
Anatomy
Brain
Decision
2025-02-14
FDA-cleared K241719

NeuroICH

Neurocareai Inc.

Authorized purpose: Notify hospital-network clinicians and neurovascular or neurosurgical specialists of suspected ICH on acute non-contrast head CT in parallel with standard-of-care interpretation; it is not a diagnostic device.

Modality
CT/CTA
Anatomy
Brain, with intracranial hemorrhage (ICH) subtypes including extradural, subdural, subarachnoid, intraparenchymal, and intraventricular hemorrhage.
Decision
2024-11-07
FDA-cleared K241480

JBS-LVO

JLK, Inc.

Authorized purpose: Notification-only parallel workflow analysis of acute brain CTA to identify suspected large-vessel occlusion in the terminal ICA or MCA-M1 and notify a neurovascular specialist for image review; the finding is not for diagnosis beyond notification.

Modality
CT/CTA
Anatomy
Brain; terminal intracranial ICA and MCA-M1 vessels
Decision
2024-09-27
FDA-cleared K242292

uAI Easy Triage ICH

Shanghai United Imaging Intelligence Co., Ltd.

Authorized purpose: Assist hospital networks and trained radiologists with workflow triage by flagging and prioritizing non-enhanced head CT studies with suspected intracranial hemorrhage.

Modality
CT/CTA
Anatomy
Head/brain; intracranial hemorrhage
Decision
2024-09-24
FDA-cleared K240353

Hyper Insight - ICH

SK Inc.

Authorized purpose: Notification-only triage for suspected acute intracranial hemorrhage on non-contrast brain CT, sharing cases with medical specialists in parallel with standard care.

Modality
CT/CTA
Anatomy
Brain
Decision
2024-07-01
FDA-cleared K233247

Heuron ICH

Heuron Co., Ltd.

Authorized purpose: Triage and notification of suspected intracranial hemorrhage on non-contrast head CT in adults and transitional adolescents aged 18 years and older, to assist prioritization while full images remain subject to standard-of-care interpretation.

Modality
CT/CTA
Anatomy
Head/brain
Decision
2024-05-15
FDA-cleared K233582

Rapid

iSchema View Inc.

Authorized purpose: Rapid is image-viewing, processing, and analysis software for DICOM CT, CT perfusion, CT angiography, C-arm CT perfusion, and MRI data, including perfusion maps and acute-stroke selection support under the labeled occlusion and imaging criteria.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Brain, cerebral vasculature, and perfusion regions
Decision
2024-04-22
FDA-cleared K232431

syngo.CT Brain Hemorrhage

Siemens Medical Solutions USA, Inc.

Authorized purpose: Assist radiologists in prioritizing suspected intracranial hemorrhage, including subarachnoid hemorrhage, on non-contrast head CT through case-level worklist output; the output is informational and not diagnostic.

Modality
CT/CTA
Anatomy
Head/brain, including intracranial and subarachnoid spaces
Decision
2024-03-22
FDA-cleared K232363

Viz HDS, Viz Volume Plus, Viz ICH+

Viz.ai, Inc.

Authorized purpose: Automatically label, visualize, and quantify segmentable brain structures on single-time-point non-contrast head CT, including intracranial hyperdensities, lateral ventricles, and midline shift; output must be reviewed with the original images by a physician.

Modality
CT/CTA
Anatomy
Brain (intracranial hyperdensities, lateral ventricles, and midline shift)
Decision
2024-02-05
FDA-cleared K232156

Rapid ASPECTS (v3)

iSchemaView, Inc.

Authorized purpose: Adjunct assessment of early ischemic brain tissue injury and extent of disease in adult ischemic-stroke diagnostic imaging workup, typically within 24 hours of last known well

Modality
CT/CTA
Anatomy
Brain/head ASPECTS regions
Decision
2024-01-19
FDA-cleared K233512

Rapid (6.0)

iSchemaView, Inc.

Authorized purpose: Rapid Platform v6.0 is image-processing software for trained professionals that views, processes, and analyzes DICOM images from CT and MRI. It supports functional and dynamic datasets including CT perfusion, CT angiography, diffusion-weighted MRI, and dynamic contrast-enhanced CT or MRI, with maps and measurements for tissue perfusion, diffusion, and blood volume. Rapid CT-Perfusion and Rapid MR-Perfusion may aid physicians in selecting acute stroke patients with known occlusion of the intracranial internal carotid artery or proximal middle cerebral artery for endovascular thrombectomy, subject to the labeled imaging criteria, clinical requirements, and exclusions.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Brain and intracranial vessels represented in CT perfusion, CTA, and MRI; tissue perfusion, diffusion, and contrast dynamics
Decision
2024-01-16
FDA-cleared K231570

StrokeViewer Perfusion

NICo-Lab B.V.

Authorized purpose: Provide quantitative perfusion information in brain tissue for suspected ischemic stroke patients using dynamic brain CT perfusion studies; medical imaging professionals use the information as additional data in the standard-of-care assessment, not as a standalone diagnostic tool.

Modality
CT/CTA
Anatomy
Brain
Decision
2023-12-14
FDA-cleared K232496

Brainomix 360 Triage Stroke

Brainomix Limited

Authorized purpose: Analyze non-contrast head CT images to help hospital networks and trained clinicians triage and prioritize suspected positive findings for intracranial ICA/M1 large-vessel occlusion and intracranial hemorrhage in adults in the acute setting within 24 hours of symptom onset or, when unclear, since last known well; the device is not a primary diagnostic device or rule-out device.

Modality
CT/CTA
Anatomy
Head/brain; intracranial ICA and M1 for LVO and intracranial hemorrhage
Decision
2023-11-21
FDA-cleared K232436

Rapid SDH

iSchemaView, Inc.

Authorized purpose: Triage and notification of suspected hemispheric subdural hemorrhage (SDH) on non-enhanced head CT, in parallel with standard-of-care interpretation; not diagnostic.

Modality
CT/CTA
Anatomy
Head, specifically hemispheric subdural space
Decision
2023-10-25
FDA-cleared K230074

Rapid Aneurysm Triage and Notification

iSchemaView Inc.

Authorized purpose: Assist hospital networks and trained radiologists in routine-care workflow triage by flagging and prioritizing adult studies with suspected unruptured saccular brain aneurysms at least 4 mm in diameter; compressed previews are informational and not for diagnostic use.

Modality
CT/CTA
Anatomy
Brain and intracranial arteries
Decision
2023-07-27
FDA-cleared K231195

Brainomix 360 Triage ICH

Brainomix Limited

Authorized purpose: Provide notification-only parallel workflow triage of adult non-contrast brain CT studies acquired in the acute setting within 24 hours of symptom onset or since last known well when onset is unclear, notifying a specialist when intracranial hemorrhage is suspected.

Modality
CT/CTA
Anatomy
Brain
Decision
2023-07-27
FDA-cleared K223240

Annalise Enterprise CTB Triage Trauma

Annalise-AI Pty Ltd

Authorized purpose: Triage and prioritization of adult CTB studies suggestive of acute subdural/epidural hematoma, acute subarachnoid hemorrhage, intra-axial hemorrhage, or intraventricular hemorrhage; the findings are intended to be used together.

Modality
CT/CTA
Anatomy
Brain
Decision
2023-04-03
FDA-cleared K222884

Rapid NCCT Stroke

iSchemaView, Inc.

Authorized purpose: Triage and notification for suspected intracranial hemorrhage and non-contrast CT large-vessel occlusion involving the ICA and MCA-M1.

Modality
CT/CTA
Anatomy
Brain/head, including ICH and ICA/MCA-M1 LVO findings.
Decision
2023-03-02
FDA-cleared K221716

CINA

AVICENNA.AI

Authorized purpose: CINA analyzes non-enhanced head CT and head CTA DICOM in parallel with standard interpretation to flag suspected intracranial hemorrhage and anterior-circulation large-vessel occlusion (distal ICA, MCA-M1 or proximal MCA-M2), issuing worklist and active notifications with informational previews for trained-radiologist triage; it does not diagnose or alter original images.

Modality
CT/CTA
Anatomy
Brain
Decision
2022-11-22
FDA-cleared K221456

Rapid ICH

iSchemaView Inc.

Authorized purpose: Assist hospital networks and trained radiologists with workflow triage by flagging and communicating suspected IPH, IVH, SAH, and SDH findings in non-enhanced head CT images.

Modality
CT/CTA
Anatomy
Head/brain; suspected intraparenchymal, intraventricular, subarachnoid, and subdural intracranial hemorrhage.
Decision
2022-09-12
FDA-cleared K220439

Viz SDH

Viz.ai, Inc.

Authorized purpose: Notification-only parallel workflow for identifying and communicating images of patients with suspected subdural hemorrhage from non-contrast head CT to neurovascular or neurosurgical specialists; not diagnostic beyond notification.

Modality
CT/CTA
Anatomy
Brain
Decision
2022-07-25
FDA-cleared K221248

Rapid LVO

iSchemaView Inc.

Authorized purpose: Assist hospital networks and trained radiologists with workflow triage by flagging and communicating suspected ICA or MCA-M1 large-vessel occlusion findings in head CTA images.

Modality
CT/CTA
Anatomy
Head/brain vasculature, specifically the intracranial ICA and MCA-M1 segments.
Decision
2022-05-31
FDA-cleared K221240

BriefCase

Aidoc Medical, Ltd.

Authorized purpose: BriefCase is a radiological computer aided triage and notification software indicated for use in the analysis of nonenhanced head CT images in adults or transitional adolescents aged 18 and older. The device is intended to assist hospital networks and appropriately trained medical specialists in workflow triage by flagging and communication of suspected positive findings of Intracranial hemorrhage (ICH) pathologies. Briefcase uses an artificial intelligence algorithm to analyze images and highlight cases with detected findings on a Stand-Alone Performance desktop application in parallel to the ongoing standard of care image interpretation. The user is presented with notification for cases with suspected findings. Notifications include compressed preview images that are meant for informational purposes only and not intended for diagnostic use beyond notification. The device does not alter the original medical image and is not intended to be used as a diagnostic device. The results of BriefCase are intended to be used in conjunction with other patient information and based on their professional judgment, to assist with triage/prioritization of medical images. Notified clinicians are responsible for viewing full images per the standard of care.

Modality
CT/CTA
Anatomy
Brain
Decision
2022-05-17
FDA-cleared K213165

Rapid

iSchema View Inc.

Authorized purpose: Rapid processes CT, CTP, CTA, diffusion MRI, and dynamic-contrast MRI for stroke viewing, perfusion, volumetry, mismatch, and large-vessel-density support for trained professionals.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Brain
Decision
2022-02-08
FDA-cleared K212116

VBrain-OAR

Vysioneer Inc.

Authorized purpose: VBrain-OAR provides the cleared image-processing and organ-at-risk contouring support described in K212116 for brain radiotherapy planning, with all contours requiring professional review and approval.

Modality
Radiotherapy Planning Imaging
Anatomy
Brain and intracranial organs at risk
Decision
2021-10-12
FDA-cleared K211222

qER-Quant

Qure.ai Technologies

Automatic labeling, visualization, and quantification of segmentable brain structures from non-contrast head CT, including intracranial hyperdensities, lateral ventricles, and midline shift; single-timepoint volumes and longitudinal comparisons are provided when scans use the same scanner and protocol for the same person.

Modality
CT/CTA
Anatomy
Brain; intracranial hyperdensities, lateral ventricles, and midline shift
Decision
2021-07-30
FDA-cleared K211788

HALO

Nico.Lab B.V.

HALO is a notification only cloud-based image processing software application using artificial intelligence algorithms to analyze patient imaging data in parallel to the standard of care imaging interpretation. Its intended use is to identify suggestive imaging patterns of a pre-specified clinical condition and to directly notify an appropriate medical specialist. HALO's indication is to facilitate the evaluation of the brain vasculature on patients suspected of stroke by processing and analyzing CT angiograms of the brain acquired in an acute setting. After completion of the data analysis, HALO sends a notification if a pattern suggestive for a suspected intracranial Large Vessel Occlusion (LVO) of the anterior circulation (ICA,MI or M2) has been identified an image. The intended users of HALO are defined as medical specialists or a team of specialists that are involved in the diagnosis and care of stroke patients at emergency departments or other department where stroke patients are administered. They include physicians such as neurologists, radiologists, and/or other emergency department physicians. HALO's output should not be used for primary diagnosis or clinical decisions; the final diagnosis is always decided upon by the medical specialist. HALO is indicated for CT scanners from GE Healthcare and Philips.

Modality
CT/CTA
Anatomy
Brain
Decision
2021-07-08
FDA-cleared K210209

Viz ICH

Viz.ai, Inc.

Authorized purpose: Notification-only, parallel workflow tool for hospital networks and trained clinicians that analyzes acute non-contrast brain CT and communicates suspected intracranial hemorrhage to a neurovascular or neurosurgical specialist for review.

Modality
CT/CTA
Anatomy
Head/brain; suspected intracranial hemorrhage.
Decision
2021-03-23
FDA-cleared K203508

BriefCase

Aidoc Medical, Ltd.

Authorized purpose: BriefCase analyzes supported noncontrast head CT, head CTA, noncontrast cervical-spine CT, and CTPA examinations to triage suspected intracranial hemorrhage, large-vessel occlusion, cervical-spine fracture-related findings, and pulmonary embolism-related findings for trained professional review.

Modality
CT/CTA
Anatomy
Adult head, brain, cervical spine, pulmonary arteries, and thorax
Decision
2020-12-29
FDA-cleared K200873

HALO

NICo-Lab B.V.

Authorized purpose: HALO analyzes contrast-enhanced brain CTA in the acute setting for suspected anterior-circulation large-vessel occlusion and provides notification support for emergency stroke specialists; the output is not a primary diagnosis.

Modality
CT/CTA
Anatomy
Brain
Decision
2020-11-20
FDA-cleared K200750

Neuro.Al Algorithm

TeraRecon, Inc.

Authorized purpose: Neuro.Al Algorithm processes static, functional, dynamic, and derived CT or MR images to support brain perfusion analysis, tissue blood-volume and parametric-map review, ventricular visualization, and DICOM return to clinical viewers for trained professional interpretation.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Brain and intracranial perfusion regions
Decision
2020-11-06
FDA-cleared K200760

Rapid ASPECTS

iSchemaView Inc.

Authorized purpose: Adjunct evaluation of extent of early ischemic brain injury in patients with known MCA or ICA occlusion during stroke imaging interpretation within 6 hours

Modality
CT/CTA
Anatomy
Brain/head ASPECTS regions
Decision
2020-06-26
FDA-cleared K200855

CINA

AVICENNA.AI

Authorized purpose: CINA analyzes nonenhanced head CT for suspected intracranial hemorrhage and head CTA for suspected large-vessel occlusion for computer-aided triage and notification in parallel with standard care; the output is not a primary diagnosis.

Modality
CT/CTA
Anatomy
Brain
Decision
2020-06-24
FDA-cleared K200921

qER

Qure.ai Technologies

qER is a radiological computer aided triage and notification software indicated for use in the analysis of non-contrast head CT images. The device is intended to assist hospital networks and trained medical specialists in workflow triage by flagging the following suspected positive findings of pathologies in head CT images: intracranial hemorrhage, mass effect, midline shift and cranial fracture. qER uses an artificial intelligence algorithm to analyze images on a Stand-Alone Performance cloud-based application in parallel to the ongoing standard of care image interpretation.

Modality
CT/CTA
Anatomy
Brain
Decision
2020-06-17
FDA-cleared K193351

NinesAI

Nines, Inc.

Authorized purpose: Provides a parallel triage workflow for head CT images with suspected intracranial hemorrhage and/or mass effect for radiologist prioritization.

Modality
CT/CTA
Anatomy
Brain
Decision
2020-04-21
FDA-cleared K193087

Rapid ICH

iSchemaView Incorporated

Authorized purpose: Notification-only triage of adult noncontrast head CT for suspected intracranial hemorrhage; results do not replace diagnostic interpretation.

Modality
CT/CTA
Anatomy
Brain
Decision
2020-03-31
FDA-cleared K193658

Viz ICH

Viz.ai, Inc.

Authorized purpose: Notification-only triage of adult noncontrast head CT for suspected intracranial hemorrhage, with specialist notification; results do not replace diagnostic interpretation.

Modality
CT/CTA
Anatomy
Brain
Decision
2020-03-18
FDA-cleared K182875

DeepCT

Deep01 Limited

Authorized purpose: Notification-only, parallel-workflow triage that identifies and communicates acute non-contrast brain CT studies with suspected ICH to a specialist for image review; not for diagnosis beyond notification.

Modality
CT/CTA
Anatomy
Brain, for suspected intracranial hemorrhage and/or hematoma.
Decision
2019-07-10
FDA-cleared K190424

HealthICH

Zebra Medical Vision Ltd.

Authorized purpose: Case-level triage of adult non-contrast head CT examinations with features suggestive of intracranial hemorrhage (ICH); not a diagnostic or rule-out tool.

Modality
CT/CTA
Anatomy
Head/brain
Decision
2019-06-13
FDA-cleared K190072

BriefCase

Aidoc Medical, Ltd.

Authorized purpose: BriefCase is a radiological computer aided triage and notification software indicated for use in the analysis of non-enhanced CT and CTPA images. The device is intended to assist hospital networks and trained radiologists in workflow triage by flagging and communication of suspected positive findings of Intracranial Hemorrhage and Pulmonary Embolism pathologies. For the PE pathology, the software is only intended to be used on single-energy exams.

Modality
CT/CTA
Anatomy
Brain; Chest/Lung
Decision
2019-04-15
FDA-cleared K182130

iSchemaView RAPID

iSchemaView, Inc.

Authorized purpose: iSchemaView RAPID processes CT perfusion, CTA, and MR studies to visualize and analyze diffusion and perfusion, including tissue blood-volume maps, and supports physician selection of eligible acute-stroke patients with known intracranial ICA or proximal MCA occlusion for thrombectomy.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Brain, intracranial vasculature, and perfusion regions
Decision
2018-12-27
FDA-cleared K182177

Accipiolx

MaxQ-Al Ltd.

Authorized purpose: Accipiolx prioritizes adult noncontrast head CT studies for cases with acute intracranial hemorrhage by sending studies from PACS to an analysis engine and returning case-level worklist priority; it is not a standalone diagnostic or rule-out system.

Modality
CT/CTA
Anatomy
Adult head and brain; acute intracranial hemorrhage
Decision
2018-10-26
FDA-cleared K180647

BriefCase

Aidoc Medical, Ltd.

Authorized purpose: BriefCase provides computer-assisted triage and notification for suspected intracranial hemorrhage on noncontrast head CT and or large-vessel occlusion on head CTA in parallel with standard care; it does not provide a primary diagnosis.

Modality
CT/CTA
Anatomy
Brain
Decision
2018-08-01
FDA-cleared K173939

Quantib Brain

Quantib BV

Authorized purpose: Automatic brain-structure labeling, visualization, volumetric quantification, and WMH-candidate assessment as complementary information for trained professionals evaluating MR brain images and preparing quantitative reports.

Modality
MRI
Anatomy
Brain structures including grey matter, white matter, cerebrospinal fluid, intracranial volume, and white matter hyperintensity candidates
Decision
2018-03-09